Ahmed R, Chapman S A, Tantrige P, Hussain A, Johnston E W, Fang C, Ammar T, Huang D Y, Wilkins C J, Garzillo G, Yusuf G T
Department of Radiology, King's College Hospital, Denmark Hill, London, SE5 9RS, UK.
Cardiovasc Intervent Radiol. 2019 May;42(5):770-774. doi: 10.1007/s00270-019-02189-7. Epub 2019 Mar 1.
Renal patients with a tunnelled haemodialysis line are at risk of fibrin 'sheath' formation which can lead to occlusion. Dysfunctional lines are best treated by catheter exchange with a new subcutaneous tunnel; however, there is a risk of scarring, venous stenosis, potential loss of valuable access as well as the risk of infection.
We report a retrospective review of our experience using tunnelled line intraluminal plasty (TuLIP) in 11 patients over 16 months with fibrin sheath formation on pre-existing tunnelled haemodialysis catheters.
All patients responded well to treatment with median line patency post TuLIP reaching 112 days.
TuLIP may have a role in extending catheter lifespan and delaying more invasive intervention.
带有隧道式血液透析导管的肾病患者存在形成纤维蛋白“鞘”的风险,这可能导致导管堵塞。功能失调的导管最好通过更换新的皮下隧道导管来治疗;然而,存在瘢痕形成、静脉狭窄、可能失去宝贵的血管通路以及感染风险。
我们报告了一项回顾性研究,总结了我们在16个月内对11例在已有的隧道式血液透析导管上形成纤维蛋白鞘的患者使用隧道式导管腔内血管成形术(TuLIP)的经验。
所有患者对治疗反应良好,TuLIP术后导管通畅的中位时间达到112天。
TuLIP可能在延长导管使用寿命和推迟更具侵入性的干预方面发挥作用。